Molven A, Hollister-Lock J, Hu J, Martinez R, Nj\olstad PR, Liew CW, Weir G, Kulkarni RN. The Hypoglycemic Phenotype Is Islet Cell–Autonomous in Short-Chain Hydroxyacyl-CoA Dehydrogenase–Deficient Mice. Diabetes. 2016;65(6):1672–1678.

Dhawan S, Dirice E, Kulkarni RN, Bhushan A. Inhibition of TGF-β signaling promotes human pancreatic β-cell replication. Diabetes. 2016;65(5):1208–1218.

Kahraman S, Okawa ER, Kulkarni RN. Is Transforming Stem Cells to Pancreatic Beta Cells Still the Holy Grail for Type 2 Diabetes?. Current diabetes reports. 2016;16(8):70.

Takatani T, Shirakawa J, Roe MW, Leech CA, Maier BF, Mirmira RG, Kulkarni RN. IRS1 deficiency protects β-cells against ER stress-induced apoptosis by modulating sXBP-1 stability and protein translation. Scientific reports. 2016;6:34969.

Shirakawa J, Kulkarni RN. Novel factors modulating human β-cell proliferation. Diabetes, Obesity and Metabolism. 2016;18:71–77.

Mezza T, Shirakawa J, Martinez R, Hu J, Giaccari A, Kulkarni RN. Nuclear export of FoxO1 is associated with ERK signaling in β-cells lacking insulin receptors. Journal of Biological Chemistry. 2016;291(41):21485–21495.

Takatani T, Shirakawa J, Roe MW, Leech CA, Maier BF, Mirmira RG, Kulkarni RN. IRS1 deficiency protects β-cells against ER stress-induced apoptosis by modulating sXBP-1 stability and protein translation. Scientific reports. 2016;6:28177.

Valdez IA, Teo AK, Kulkarni RN. Cellular stress drives pancreatic plasticity. Science translational medicine. 2015;7(273):273ps2–273ps2.

Stewart AF, Hussain MA, ia-Oca\~na AG \, Vasavada RC, Bhushan A, Bernal-Mizrachi E, Kulkarni RN. Human β-Cell Proliferation and Intracellular Signaling: part 3. Diabetes. 2015;64(6):1872–1885.

Al-Share QY, DeAngelis AM, Lester SG, Bowman TA, Ramakrishnan SK, Abdallah SL, Russo L, Patel PR, Kaw MK, Raphael CK, et al. Forced hepatic overexpression of CEACAM1 curtails diet-induced insulin resistance. Diabetes. 2015;64(8):2780–2790.